Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study of JNJ-70033093 and Digoxin in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Cabozantinib and Nivolumab for Carcinoid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy
- Status
- COMPLETED
- Phase
- N/A
A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- N/A
Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of Single and Multiple Doses of BMS-986209 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients
- Status
- UNKNOWN
- Phase
- N/A
A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)
- Status
- TERMINATED
- Phase
- PHASE3